Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

被引:0
|
作者
Mingchu Sun
Wenhua Jiang
Nan Mu
Zihui Zhang
Lu Yu
Heng Ma
机构
[1] Northwestern Polytechnical University,Institute of Medical Research
[2] Fourth Military Medical University,Department of Physiology and Pathophysiology, School of Basic Medical Sciences
[3] Fourth Military Medical University,Department of Pathology, Xijing Hospital
关键词
Cardiovascular diseases; Mitochondrial dysfunction; Mitochondrial transplantation; Ischemia reperfusion injury; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.
引用
收藏
相关论文
共 50 条
  • [41] The Impact of Novel Treatment Modalities on the Therapeutic Approach of Cardiovascular Diseases
    Paraskevas, Kosmas I.
    Psathas, Chrisovalantis
    Dragios, Theodoros
    Chatzis, Dimitrios G.
    Mikhailidis, Dimitri P.
    Kyriakides, Zenon S.
    ANGIOLOGY, 2009, 60 (01) : 5 - 7
  • [42] ACE2: A novel therapeutic target for cardiovascular diseases
    Der Sarkissian, S
    Huentelman, MJ
    Stewart, J
    Katovich, MJ
    Raizada, MK
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2006, 91 (1-2): : 163 - 198
  • [43] Design of therapeutic vaccines as a novel antibody therapy for cardiovascular diseases
    Nakagami, Hironori
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 201 - 205
  • [44] Novel Therapeutic Approaches and Targets for the Treatment of Cardiovascular and Immunological Diseases
    Campi, Giacomo
    Mercurio, Valentina
    Fabiani, Dario
    Grieco, Martina
    Russo, Michele
    Tocchetti, Carlo G.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (09) : 684 - 685
  • [45] Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases
    Zhong, Jiu-Chang
    Zhang, Zhen-Zhou
    Wang, Wang
    McKinnie, Shaun M. K.
    Vederas, John C.
    Oudit, Gavin Y.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (08): : 1942 - 1950
  • [46] Modulation of mitochondrial KATP channels. A new therapeutic target for cardiovascular diseases
    Grover, GJ
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (06) : A147 - A147
  • [47] Mitochondrial calcium uniporter complex: An emerging therapeutic target for cardiovascular diseases (Review)
    Li, Yaling
    Hu, Hongmin
    Chu, Chun
    Yang, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2025, 55 (03)
  • [48] Targeting stress granules: A novel therapeutic strategy for human diseases
    Wang, Fei
    Li, Juan
    Fan, Shengjie
    Jin, Zhigang
    Huang, Cheng
    PHARMACOLOGICAL RESEARCH, 2020, 161
  • [49] Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
    Mutalub, Yahkub Babatunde
    Abdulwahab, Monsurat
    Mohammed, Alkali
    Yahkub, Aishat Mutalib
    AL-Mhanna, Sameer Badri
    Yusof, Wardah
    Tang, Suk Peng
    Rasool, Aida Hanum Ghulam
    Mokhtar, Siti Safiah
    FOODS, 2022, 11 (17)
  • [50] Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases
    Klein, Kerstin
    RMD OPEN, 2018, 4 (02):